CDKN1A and neoplasm: Notably, we verified that DNASE1L3 can inhibit the entry of β‐catenin into the nucleus using nucleocytoplasmic separation assay, and obstruct the expression levels of downstream targets (c‐Myc, P21 and P27), eventually regulated β‐catenin‐related tumour properties and EMT signals.